Cytek Biosciences, Inc. Common Stock (CTKB) is a publicly traded Healthcare sector company. As of September 1, 2026, CTKB trades at $4.62 with a market cap of $621.32M and a P/E ratio of 0.00. CTKB moved -3.45% today. Year to date, CTKB is -6.10%; over the trailing twelve months it is +14.93%. Its 52-week range spans $2.37 to $7.30. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces CTKB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest CTKB news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.62 |
| Market Cap | $621.32M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.30 |
| 52-Week Low | $2.37 |
| Volume | 520.37K |
| Avg Volume | 0 |
| Revenue (TTM) | $206.71M |
| Net Income | $-80.58M |
| Gross Margin | 53.23% |
3 analysts cover CTKB: 0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.